LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 26,393 Value ($000) $12 Avg Close $0.59 Range $0.45 - $0.75
Q4 2024
Shares 185,908 Value ($000) $93 Avg Close $0.73 Range $0.48 - $0.97
Q3 2024
Shares 191,436 Value ($000) $173 Avg Close $0.93 Range $0.77 - $1.15
Q2 2024
Shares 207,764 Value ($000) $207 Avg Close $1.10 Range $0.84 - $1.56
Q1 2024
Shares 206,243 Value ($000) $305 Avg Close $1.13 Range $0.84 - $1.61
Q4 2023
Shares 162,683 Value ($000) $177 Avg Close $1.10 Range $0.90 - $1.37
Q3 2023
Shares 182,561 Value ($000) $215 Avg Close $1.36 Range $1.15 - $1.54
Q2 2023
Shares 253,275 Value ($000) $357 Avg Close $1.38 Range $1.24 - $1.57
Q1 2023
Shares 241,022 Value ($000) $362 Avg Close $1.40 Range $1.16 - $1.58
Q4 2022
Shares 261,902 Value ($000) $306 Avg Close $1.26 Range $1.02 - $1.51
Q3 2022
Shares 288,299 Value ($000) $326 Avg Close $1.47 Range $1.11 - $1.79
Q2 2022
Shares 135,328 Value ($000) $214 Avg Close $1.32 Range $1.10 - $1.64
Q1 2022
Shares 12,000 Value ($000) $18 Avg Close $1.55 Range $1.18 - $2.58
Q3 2020
Shares 14,601 Value ($000) $14 Avg Close $0.88 Range $0.73 - $1.14
Q2 2020
Shares 56,541 Value ($000) $49 Avg Close $0.88 Range $0.70 - $1.20
Q1 2020
Shares 50,718 Value ($000) $42 Avg Close $1.00 Range $0.58 - $1.67
Q4 2019
Shares 22,150 Value ($000) $20 Avg Close $0.83 Range $0.53 - $1.02